跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GP-7
首页
药物
GP-7
GP-7
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SiRNA of m6A recognition protein IGF2BP family gene and application thereof
申请人: SHANGHAI GENEPHARMA CO LTD
优先权: 2023
CN
SiRNA of m6A recognition protein HNRNP related gene and application thereof
申请人: SHANGHAI GENEPHARMA CO LTD
优先权: 2023
CN
SiRNA of m6A methyltransferase and related recognition factor gene and application thereof
申请人: SHANGHAI GENEPHARMA CO LTD
优先权: 2023
CN
Dimethoxy tetrahydroisoquinoline substituted purine derivative as well as preparation method and application thereof in anti-tumor drugs
申请人: LIN JIANXIONG
优先权: 2021
CN
Carboxylated beta-GP bi-crosslinking ABPA, tearable mask and preparation method
申请人: UNIV CHANGCHUN CHINESE MEDICINE
优先权: 2026
CN
Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
申请人: ASTEX THERAPEUTICS LTD
优先权: 2006
CN
SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETY
申请人: ASTEX THERAPEUTICS LTD
优先权: 2007
US
Application of praeruptorin B in preparation of medicine for reversing multidrug resistance of tumor
申请人: SECOND MILITARY MEDICAL UNIV
优先权: 2023
CN
药物
反馈